StoneX Groupの空売り状況は、投資家がStoneX Groupの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

StoneX Group (NASDAQ:SNEX) 株価情報, 空売り情報

StoneX Group

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: commercial, Institutional, Retail, and Global Payments. Its customers include governmental and nongovernmental organizations, and commercial banks, brokers, institutional investors, and investment banks. The company operates in United States, South America, Europe, Middle East and Asia and other countries, out of which majority revenue is generates from Middle East and Asia Region.

StoneX Group Inc

Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) just disclosed its Q1 earnings on Tuesday, November 26, 2024 at 04:01 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Nutanix beat estimated earnings by 31.0%, reporting an EPS of $0.42 versus an estimate of $0.32.
Revenue was up $79.90 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
In the previous quarter, the company beat on EPS by $0.07, resulting in a 20.0% increase change in the share price the following day.
Here's a look at Nutanix's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.16</td>
<td>0.29</td>
<td>0.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.27</td>
<td>0.28</td>
<td>0.46</td>
<td>0.29</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>536.94M</td>
<td>516.18M</td>
<td>551.34M</td>
<td>501.32M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>547.95M</td>
<td>524.58M</td>
<td>565.23M</td>
<td>511.05M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Nutanix <a href="https://www.benzinga.com/quote/NTNX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

NTNX

Insights into Nutanix Q1 Earnings

News

Guidance

Nordstrom Continues To Expect FY24 Adjusted EPS Of $1.75 - $2.05 (Est $1.89)

WIIM

DELL

Dell Technologies shares are trading lower following a Q3 revenue miss.

WDAY

Workday shares are trading lower after the company revised its FY25 subscription revenue guidance,

NKGen Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) ("NKGen" or the "Company"), today announced it received a notice (the "Notice") on November 20, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because it had not timely filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q") with the Securities and Exchange Commission (the "SEC") on or before November 19, 2024, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended. The delay is in part due to the additional time required for valuation and review of various derivative securities as the Company has taken on more reporting responsibility internally. The Notice from Nasdaq has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Market.
The Company is actively working with its auditors and advisors and intends to file the Form 10-Q as promptly as possible.
On November 20, 2024, subsequent to the Company's receipt of the Notice, the Company received a letter from Nasdaq (the "Decision Letter") granting a temporary exception to the Rule and the minimum market value of listed securities requirement in Nasdaq Listing Rule 5450(b)(2)(A) (the "MVLS Rule") until January 7, 2025. The Seoul Bankruptcy Court (the "Court") is expected to announce its decision on the rehabilitation of NKMax Co. Ltd ("NKMax") and the Company's proposal to acquire a majority interest in NKMax on or before such date. In accordance with the Decision Letter, the Company must advise the Nasdaq Hearings Panel (the "Panel") of the outcome of the Court's decision. If the Company is successful in its bid to acquire a majority interest in NKMax, the Company must advise the Panel no later than January 7, 2025, on its plan for regaining compliance with the Rule and MVLS Rule, for the Panel's further consideration.
The Company may request that the Nasdaq Listing and Hearing Review Council (the "Council") review the Panel's determination in the Decision Letter, by written request received by the Council by December 5, 2024. In such event, the Company would be required to submit a fee of $15,000.00 to Nasdaq to cover the cost of the review. The Council may determine to review any Panel decision by January 4, 2025. The Company does not intend to appeal the Decision Letter at this time and intends to deliver an updated plan of compliance to the Panel no later than January 7, 2025.

NKGN

NKGen Biotech Receives Notifications From Nasdaq Related To Delayed Quarterly Report And Decision Of The Nasdaq Hearings Panel; The Company Does Not Intend To Appeal The Decision Letter At This Time And Intends To Deliver An Updated Plan Of Compliance To The Panel No Later Than January 7, 2025.

For fiscal 2025, HP anticipates generating free cash flow in the range of $3.2 to $3.6 billion.

HP Expects Adj EPS Of $0.70 - $0.76 For Q1 (Est $0.85); $3.45 - $3.75 For FY25 (Est $3.60)

Guess Sees FY25 EPS $0.70-$0.82; Adj. EPS $1.85-$2.00.

<a href="https://www.globenewswire.com/Tracker?data=RStI-Eh5ZELBq7ZL7G-QBxlErYxTLAPvtV51a1k8H3KnWszbj2ti19uebhw7GWFQ3ce_q6rFvE8kHIB45a22cePjTzLcXiJ3Yvs4Bydq8dE=">Middlesex Water Company</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSEX#NASDAQ">MSEX</a>), a provider of water and wastewater and related services primarily in New Jersey and Delaware, today announced that Gregory Sorensen has been named as its Vice President and Chief Operating Officer, effective December 16, 2024, as part of ongoing strategic succession planning and organizational realignment efforts.

Management

MSEX

Middlesex Water Names Gregory Sorensen VP And COO, Effective December 16, 2024, As Part Of Ongoing Strategic Succession Planning And Organizational Realignment Efforts.

Regional Health Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RHE#AMEX">RHE</a>) reported quarterly losses of $(0.52) per share. This is unchanged from the same period last year. The company reported $4.22 million in sales this quarter. This is a 2.10 percent increase over sales of $4.14 million the same period last year.

Regional Health Props Q3 EPS $(0.52), Same YoY, Sales $4.22M Up From $4.14M YoY

Guess? Q3 2025 Adj. EPS $0.34 Down From $0.49 YoY, Sales $739.0M Up From $651.1M YoY

The earnings results for Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) for Q3 were made public on Tuesday, November 26, 2024 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Urban Outfitters beat estimated earnings by 28.999999999999996%, reporting an EPS of $1.1 versus an estimate of $0.85.
Revenue was up $81.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
Last quarter the company beat on EPS by $0.24 which was followed by a 10.0% drop in the share price the next day.
Here's a look at Urban Outfitters's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1</td>
<td>0.51</td>
<td>0.73</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.24</td>
<td>0.69</td>
<td>0.69</td>
<td>0.88</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.34B</td>
<td>1.17B</td>
<td>1.49B</td>
<td>1.26B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.35B</td>
<td>1.20B</td>
<td>1.49B</td>
<td>1.28B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Urban Outfitters <a href="https://www.benzinga.com/quote/URBN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

URBN

Earnings Summary: Urban Outfitters Q3

HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) just disclosed its Q4 earnings on Tuesday, November 26, 2024 at 04:15 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
HP missed estimated earnings by 0.0%, reporting an EPS of $0.93 versus an estimate of $0.93.
Revenue was up $238.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
Last quarter the company missed on EPS by $0.03 which was followed by a 2.0% increase in the share price the next day.
Here's a look at HP's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.86</td>
<td>0.81</td>
<td>0.81</td>
<td>0.9</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.83</td>
<td>0.82</td>
<td>0.81</td>
<td>0.9</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>13.38B</td>
<td>12.60B</td>
<td>13.51B</td>
<td>13.81B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>13.52B</td>
<td>12.80B</td>
<td>13.19B</td>
<td>13.82B</td>
</tr>
</tbody>
</table>

To track all earnings releases for HP <a href="https://www.benzinga.com/quote/HPQ/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HP Earnings Report: Q4 Overview

- SAN711 is a first-in-class, highly selective GABAA-α3 positive allosteric modulator
- Targeting initiation of Phase 2 study of SAN711 for the treatment of essential tremor in 2026
Acadia Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) today announced it has entered into an exclusive worldwide license agreement with Saniona (OMX: SANION) for the development and commercialization of SAN711, a first-in-class, highly selective GABAA-α3 positive allosteric modulator. The first indication the Company plans to pursue is development of SAN711 for essential tremor, a neurological condition that includes shaking or trembling movements in one or more parts of the body. Acadia is planning to initiate a Phase 2 study of SAN711 in essential tremor in 2026.
"Licensing SAN711 to expand our pipeline underscores our unwavering commitment to delivering innovative therapies for patients with central nervous system disorders," said Catherine Owen Adams, Chief Executive Officer. "Essential tremor is a condition that has not seen innovation in treatment for decades, creating a compelling opportunity to address a long-overlooked need. Our work with SAN711 will draw on our deep expertise in developing and commercializing cutting-edge treatments for neurological disorders."
Under the terms of the License Agreement, Saniona will receive US $28 million upfront plus potential milestone payments of up to US $582 million. In addition, Saniona is eligible to receive tiered royalties of mid-single digits to low double digits on net sales of commercial products that may result from development of SAN711. The potential milestone payments to Saniona consist of up to US $147 million subject to achievement of development and commercial milestones related to potential first and second indications, and up to US $435 million subject to achievement of thresholds of annual net sales of SAN711 worldwide. Acadia will lead further clinical development, regulatory submissions, and global commercialization efforts for SAN711 while also providing financial support for Saniona's ongoing Phase 1 study and preparations for Phase 2.

Biotech

Contracts

General

ACAD

Acadia Pharmaceuticals Announces Exclusive License Agreement With Saniona For SAN711; Under The Terms Of The License Agreement, Saniona Will Receive $28M Upfront Plus Potential Milestone Payments Of Up To $582M

The quarterly cash dividend is payable on January 2, 2025 to stockholders of record as of the close of business on December 11, 2024. This is the first dividend of HP's 2025 fiscal year and represents an increase of 5% from the prior dividend.

Dividends

HP Raises Annual Dividend By 5%; Boosts Quarterly Cash Dividend From $0.2756 To $0.2894 Per Share

Buybacks

Installed Building Products Repriced $500M Loan

Financing

EVTV

Envirotech Vehicles Expects $25M Funding From Yorkville Advisors Global

Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) reported quarterly losses of $(1.26) per share. This is a 78.28 percent increase over losses of $(5.80) per share from the same period last year.

PRTG

Portage Biotech Q2 EPS $(1.26) Up From $(5.80) YoY

Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) reported $49.60 million in sales this quarter.

IREN

Iris Energy Q1 Sales $49.60M

Offerings

SCNX

Scienture Holdings Announces Private Placement Of $3M of 10% Secured Convertible Debentures As Initial Tranche Of $12M Offering And Entry Into $50 Million Equity Line Of Credit Agreement

HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) reported quarterly earnings of $0.93 per share which met the analyst consensus estimate. This is a 3.33 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $14.05 billion which beat the analyst consensus estimate of $13.99 billion by 0.49 percent. This is a 1.72 percent increase over sales of $13.82 billion the same period last year.

Earnings Beats

HP Q4 2024 GAAP EPS $0.93, Inline, Sales $14.05B Beat $13.99B Estimate

StoneX Group ( ($SNEX) ) has issued an update. StoneX Group Inc. has kicked off an ambitious plan to repurchase up to 1.5 million shares of its out...

StoneX Group Announces Multi-Million Share Buyback Plan

StoneX: Operational Leverage Can Boost Earnings

In a report released today, Daniel Fannon from Jefferies maintained a Buy rating on StoneX Group (SNEX – Research Report), with a price target of $...

StoneX Group (SNEX) Gets a Buy from Jefferies

StoneX Group ( ($SNEX) ) just unveiled an announcement. StoneX Group Inc. has alerted its stockholders about disclosure obligations under the UK Ci...

StoneX Group Considers Acquisition of CAB Payments

Here are the major earnings after the close today

StoneX GAAP EPS of $2.32 beats by $0.27, revenue of $31.13B

Reports Q4 operating revenue $454.8M vs. $403.7M last year. Sean M. O'Connor, the company's CEO, stated, "For the fiscal fourth quarter, net income...

StoneX Group reports Q4 EPS $2.32 vs. $1.57 last year

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp; HIGHER AFTER EARNINGS – KORE Group Holdings&nbsp;(KORE)&nbs...

Closing Bell Movers: Keysight up 9% after Q4 earnings beat

StoneX Group Inc. (SNEX) Q4 2024 Earnings Call Transcript

Stonex Group Inc. ( ($SNEX) ) has released its Q4 earnings. Here is a breakdown of the information Stonex Group Inc. presented to its investors. St...

StoneX Group Reports Record Q4 2024 Results

AVAV

AZEK

AZTA

FLEX

GBDC

KEYS

KORE

POWL

QFIN

SBLK

SGMO

SNEX

VREX

WKHS

Press Releases

StoneX Group Inc. to Announce 2024 Fiscal Second Quarter Earnings on May 8, 2024

StoneX Group Inc. Reports Fiscal 2024 Second Quarter Financial Results

StoneX Group Inc. to Announce 2024 Fiscal Third Quarter Earnings on August 6, 2024

StoneX Group Inc. Reports Fiscal 2024 Third Quarter Financial Results

StoneX completes acquisition of JBR Recovery's recycling and refining business, to deepen the company's end-to-end metals offering

Rule 8 Announcement to Stockholders

StoneX Expands with IIBX Membership, New Offices in Pune and Bengaluru, India

StoneX Announces Election Trading Partnership Between FOREX.com and Kalshi

StoneX Group Inc. to Announce 2024 Fiscal Fourth Quarter Earnings on November 19, 2024

StoneX Group Inc. Reports Fiscal 2024 Fourth Quarter Financial Results

BGC Group

Evercore

Freedom Holding

Futu Holdings Limited - American Depositary Shares

Futu Hldgs

Goldman Sachs Group, Inc. (The) Common Stock

Goldman Sachs Gr

Houlihan Lokey, Inc. Class A Common Stock

Houlihan Lokey

Robinhood Markets, Inc. - Class A Common Stock

Robinhood Markets

Interactive Brokers Group, Inc. - Class A Common Stock

Interactive Brokers Gr

Jefferies Financial Group Inc. Common Stock

Jefferies Financial Gr

Lazard

LPL Financial Holdings Inc. - Common Stock

LPL Finl Hldgs

Moelis

Morgan Stanley

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings

Oppenheimer Holdings, Inc. Class A Common Stock (DE)

Oppenheimer Hldgs

Piper Sandler

PJT Partners

Perella Weinberg Partners - Class A Common Stock

Perella Weinberg

B. Riley Financial

Raymond James Financial, Inc. Common Stock

Raymond James Finl

Charles Schwab Corporation (The) Common Stock

Charles Schwab

Stifel Financial Corporation Common Stock

Stifel Financial

UP Fintech Holding Limited - American Depositary Shares representing fifteen Class A Ordinary Shares

UP Fintech Holding

Virtu Financial, Inc. - Class A Common Stock

Comments

StoneX Group

空売り

StoneX Group (NASDAQ:SNEX) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル